Venu Krishna from Barclays recommends Vertex Pharmaceuticals (NASDAQ:VRTX) to diversify your portfolio away from big tech stocks. Vertex's strong growth catalysts and pipeline make it a smart long-term investment choice. Despite being ranked 7th, some believe AI stocks offer higher returns in a shorter timeframe.